Equities

Sinphar Pharmaceutical Co Ltd

1734:TAI

Sinphar Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)32.85
  • Today's Change0.05 / 0.15%
  • Shares traded295.49k
  • 1 Year change+9.50%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue2,9632,8572,434
OPERATING EXPENSES
Cost of revenue total1,8721,7651,545
Selling, general and admin. expenses, total673622560
Depreciation/amortization------
Unusual expense(income)------
Other operating expenses, total------
Total operating expense2,6772,6592,616
Operating income286197(183)
Other, net294828
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes306245(185)
Provision for income taxes(51)8120
Net income after taxes357164(205)
Minority interest1860167
Net income before extra. Items375225(38)
Total extraordinary items------
Net income375225(38)
Inc.avail. to common excl. extra. Items375225(38)
Inc.avail. to common incl. extra. Items375225(38)
EPS RECONCILIATION
Basic/primary weighted average shares168168168
Basic/primary eps excl. extra items2.241.34(0.23)
Basic/primary eps incl. extra items2.241.34(0.23)
Dilution adjustment--00
Diluted weighted average shares168168168
Diluted eps excl. extra items2.231.34(0.23)
Diluted eps incl. extra items2.231.34(0.23)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.001.000.20
Gross dividend - common stock16816834
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental342825
SUPPLEMENTAL INCOME
Depreciation, supplemental207201197
Total special items(7.81)(0.48)1.50
NORMALISED INCOME
Normalized income before taxes298245(183)
Effect of special items on income taxes(2.73)(0.16)0.52
Income tax excluding impact of special items(54)8121
Normalized income after tax352164(204)
Normalized income avail. to common370224(37)
Basic normalized EPS2.211.34(0.22)
Diluted normalized EPS2.201.34(0.22)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.